Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BeiGene Ltd ( (HK:6160) ) just unveiled an announcement.
BeOne Medicines Ltd., a Swiss corporation, announced it will release its unaudited financial results for the third quarter of 2025 on November 6, 2025, following the trading hours of the Hong Kong Stock Exchange. The results will be reviewed by the audit committee on the same day, and a conference call with management will be held to discuss the financials, providing stakeholders an opportunity to engage with the company’s leadership.
The most recent analyst rating on (HK:6160) stock is a Buy with a HK$236.00 price target. To see the full list of analyst forecasts on BeiGene Ltd stock, see the HK:6160 Stock Forecast page.
More about BeiGene Ltd
Average Trading Volume: 5,788,106
Technical Sentiment Signal: Buy
Current Market Cap: HK$281.5B
Learn more about 6160 stock on TipRanks’ Stock Analysis page.